Skip to Main Content

Jointly provided by

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Message from our Chair

Impact of ManagedCareEye.com Activities

Jeffrey D. Dunn, PharmD, MBA

Chief Clinical Officer

Cooperative Benefits Group (CBG)

April 13, 2023

Related Articles

Matt White, JD

← Facilitating Optimal Outcomes for the Management of Retinal Diseases: Health Plan Best Practice Recommendations Managed Care Pathway for Better Management of Retinal Vein Occlusion (RVO) Applying Health Plan Best Practices in the Treatment of Retinal Diseases – Retinopathy of Prematurity Clinical Primer →

« Return to the Homepage

About Impact Education, LLC
About Medical Education Resources
Contact Us

Privacy Policy/Disclaimer

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.